Albemarle
Albemarle Corporation’s Fine Chemistry Services business has more than 40 years of experience, dedicated to custom manufacturing. Through teamwork and a customer focus, we have established world-class facilities where we can support bench to commercial processing at one site and enable customers to take RSMs to final Active Pharmaceutical Ingredients with one US manufacturer.
Albemarle
4350 Congress St. Suite 700, Charlotte, NC 28209
ALBSales@albemarle.com
tel. 980.299.5700
CPhI North America Booth #1259
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
